Invited review: Toxicology of deoxynivalenol (vomitoxin)

BA Rotter - Journal of Toxicology and Environmental Health Part A, 1996 - Taylor & Francis
Trichothecene mycotoxins are a group of structurally similar fungal metabolites that are
capable of producing a wide range of toxic effects. Deoxynivalenol (DON, vomitoxin), a …

Hypothalamic serotonin in control of eating behavior, meal size, and body weight

SF Leibowitz, JT Alexander - Biological psychiatry, 1998 - Elsevier
Serotonin (5-HT) has been implicated in the control of eating behavior and body weight.
Stimulants of this monoamine reduce food intake and weight gain and increase energy …

Novel antipsychotics: comparison of weight gain liabilities

DA Wirshing, WC Wirshing, L Kysar… - Journal of Clinical …, 1999 - psychiatrist.com
Background: We performed a retrospective analysis of 122 clinical records of 92 male
patients with DSM-III-R schizophrenia to examine the relative weight gain liabilities of …

Current and potential drugs for treatment of obesity

GA Bray, FL Greenway - Endocrine reviews, 1999 - academic.oup.com
A. Peripherally acting agents B. Centrally acting agents IV. Drugs That Alter Metabolism A.
Preabsorptive agents B. Postabsorptive modifiers of nutrient metabolism V. Drugs That …

Novel antipsychotics and new onset diabetes

DA Wirshing, BJ Spellberg, SM Erhart, SR Marder… - Biological …, 1998 - Elsevier
Background: The new antipsychotics induce minimal extrapyramidal side effects, probably
due to their relatively greater affinity for certain nondopaminergic receptors than their older …

Long-term olanzapine treatment: weight change and weight-related health factors in schizophrenia

BJ Kinon, BR Basson, JA Gilmore… - Journal of Clinical …, 2001 - psychiatrist.com
Background: Weight change and the weightrelated health factors of nonfasting serum
glucose, serum cholesterol, and diastolic blood pressure levels were analyzed in patients …

The clinical implications of weight gain in schizophrenia

I Kurzthaler, WW Fleischhacker - Journal of Clinical Psychiatry, 2001 - psychiatrist.com
The tendency of most of the second generation antipsychotics to induce weight gain to a
larger extent than that of traditional neuroleptics has renewed the interest in weight …

Lorcaserin: A review of its preclinical and clinical pharmacology and therapeutic potential

GA Higgins, PJ Fletcher, WR Shanahan - Pharmacology & Therapeutics, 2020 - Elsevier
The selective 5-HT2C receptor agonist lorcaserin, in conjunction with lifestyle modification,
was approved by the FDA in 2012 for weight management. It has been marketed in the US …

The role of serotonin in eating disorders

SF Leibowitz - Drugs, 1990 - Springer
Recent pharmacological studies have more precisely characterised the nature of the
inhibitory effect of brain serotonin (5-hydroxytryptamine) on feeding behaviour. Thus, the …

Treatment of obesity: an update on anti‐obesity medications

A Halpern, MC Mancini - Obesity reviews, 2003 - Wiley Online Library
The information presented in this article provides an overview of physiological agents,
therapeutics in current use, and medications that have been extensively used in the past but …